See every side of every news story
Published loading...Updated

Insulet Omnipod 5 has positive study outcomes in type 2 diabetes

Summary by Drug Delivery Business
Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet]JAMA today published outcomes from a study evaluating the safety and efficacy of the Insulet Omnipod 5 in adults with type 2 diabetes. Omnipod 5, the company’s latest-generation automated insulin delivery (AID) system, became the first and only such system cleared for type 1 and type 2 diabetes last August. Insulet said at the time of its June submission to the FDA that it aimed for…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Delivery Business broke the news in on Friday, February 14, 2025.
Sources are mostly out of (0)